1 hipertensão pulmonar e esclerose sistêmica pulmonary hypertension and systemic sclerosis

2 síndrome hemofagocítica devido a sarcoidose pulmonar hemophagocytic syndrome due to pulmonary sarcoidosis

3 corticoide sistêmico como tratamento de primeira linha da hipertensão pulmonar secundária a síndrome poems systemic corticosteroids as first-line treatment in pulmonary hypertension associated with poems syndrome

4 comunicantes domiciliares jovens de pacientes com tb pulmonar na região da grande vitória (es): um estudo de coorte juvenile household contacts aged 15 or younger of patients with pulmonary tb in the greater metropolitan area of vitória, brazil: a cohort study

5 tratamento cirúrgico de aspergiloma pulmonar surgical treatment of pulmonary aspergilloma

6 Pulmonary Artery Pressure, Gender, Menopause, and Pregnancy in Schistosomiasis-Associated Pulmonary Hypertension

7 Thirteen kinds of Chinese medicine injections for acute exacerbation of chronic obstructive pulmonary disease: Protocol for a systematic review and network meta-analysis.

8 Mechanisms Underlying Spontaneous Action Potential Generation Induced by Catecholamine in Pulmonary Vein Cardiomyocytes: A Simulation Study.

9 [Hemoptysis in a case with partial pulmonary artery agenesis and diagnostic delay].

10 Delays in diagnosis of acute pulmonary thromboembolism: Clinical outcomes and risk factors

11 Increased pulmonary artery diameter is associated with reduced FEV in former World Trade Center workers.

12 Acute pulmonary thromboembolism caused by factor V Leiden mutation in South Korea: A case report.

13 Use of pulmonary artery catheter in coronary artery bypass graft. Costs and long-term outcomes.

14 TNF-α-Producing Exerts Protective Effects on Host Defenses in Murine Pulmonary Cryptococcosis.

15 Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses

16 Invasive pulmonary infection due to Thermoascus crustaceus in a kidney transplant recipient

17 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

18 Association of MBL2 gene polymorphisms with pulmonary tuberculosis susceptibility: trial sequence meta-analysis as evidence

19 Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones

20 The performance of serum cryptococcal capsular polysaccharide antigen test, histopathology and culture of the lung tissue for diagnosis of pulmonary cryptococosis in patients without HIV infection

21 Sera from patients with active pulmonary tuberculosis and their household contacts induce nuclear changes in neutrophils

22 Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016

23 New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China

24 The correlation between CT features and glycosylated hemoglobin level in patients with T2DM complicated with primary pulmonary tuberculosis

25 Performance of computed tomography versus chest radiography in patients with pulmonary tuberculosis with and without diabetes at a tertiary hospital in Riyadh, Saudi Arabia

26 Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis

27 Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia

28 Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension

29 Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease

30 Multielectrode phased radiofrequency ablation compared with point-by-point ablation for pulmonary vein isolation – outcomes in 539 patients

31 Association of MBL2 gene polymorphisms with pulmonary tuberculosis susceptibility: trial sequence meta-analysis as evidence

32 The changes of expressive levels of IL-17A, STAT3, and RORγt in different invasive pulmonary aspergillosis mice

33 Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses

34 Invasive pulmonary infection due to Thermoascus crustaceus in a kidney transplant recipient

35 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

36 Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses

37 Invasive pulmonary infection due to Thermoascus crustaceus in a kidney transplant recipient

38 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

39 Vitamin D as an Adjunctive Treatment to Standard Drugs in Pulmonary Tuberculosis Patients: An Evidence-Based Case Report

40 Inhaled Nitric Oxide as an Adjunct to Thrombolytic Therapy in a Patient with Submassive Pulmonary Embolism and Severe Hypoxemia

41 Antibody-Negative Relapse of Goodpasture Syndrome with Pulmonary Hemorrhage

42 Hydrops Fetalis and Persistent Pulmonary Hypertension in a Neonate with Anti-E Alloimmunization

43 Association of MBL2 gene polymorphisms with pulmonary tuberculosis susceptibility: trial sequence meta-analysis as evidence

44 Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones

45 The performance of serum cryptococcal capsular polysaccharide antigen test, histopathology and culture of the lung tissue for diagnosis of pulmonary cryptococosis in patients without HIV infection

46 Sera from patients with active pulmonary tuberculosis and their household contacts induce nuclear changes in neutrophils

47 Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016

48 New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China

49 The correlation between CT features and glycosylated hemoglobin level in patients with T2DM complicated with primary pulmonary tuberculosis

50 Rare Primary Pulmonary Marginal Zone Lymphoma Presenting with Incidental Pulmonary Nodules

51 Primary Pulmonary Malignant Melanoma Found While Evaluating New Onset Cough: A Case Presentation and Literature Review

52 Septic Pulmonary Embolism Secondary to Klebsiella pneumoniae Epididymitis: Case Report and Literature Review

53 Transcatheter Proximal Coil Blocking with n-Butyl-2-Cyanoacrylate Injection via the Pulmonary Artery Alone for Rasmussen’s Aneurysm

54 Performance of computed tomography versus chest radiography in patients with pulmonary tuberculosis with and without diabetes at a tertiary hospital in Riyadh, Saudi Arabia

55 Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis

56 Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia

57 Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension

58 Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease

59 Effect of Low-Level Laser Therapy (LLLT) in Pulmonary Inflammation in Asthma Induced by House Dust Mite (HDM): Dosimetry Study

60 The Clinical Rationale for the Sentry Bioconvertible Inferior Vena Cava Filter for the Prevention of Pulmonary Embolism

61 Multielectrode phased radiofrequency ablation compared with point-by-point ablation for pulmonary vein isolation – outcomes in 539 patients

62 [PARADOXICAL RESPONSE DURING TREATMENT OF PULMONARY TUBERCULOSIS].

63 Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study.

64 Unifocalization cannot rely exclusively on native pulmonary arteries: the importance of recruitment of major aortopulmonary collaterals in 249 cases†.

65 Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape.

66 The role of atopy in the pathogenesis of bleomycin pulmonary toxicity.

67 Recommendations and practices for holistic chronic obstructive pulmonary disease (COPD) assessment and optimal referral patterns in emergency department presentations: a scoping review protocol.

68 Sleep disturbance in patients with mild-moderate chronic obstructive pulmonary disease.

69 Internet Health Behaviors of Patients with Chronic Obstructive Pulmonary Disease and Assessment of Two Disease Websites.

70 Bismuth Ferrite Second Harmonic Nanoparticles for Pulmonary Macrophage Tracking.

71 CT scanning in the evaluation of pulmonary hypertension.

72 Association of Serum 25-Hydroxyvitamin D Concentration with Pulmonary Function in Young Adults.

73 Global weighted LBP based entropy features for the assessment of pulmonary hypertension

74 Virtual bronchoscopic navigation without X-ray fluoroscopy to diagnose peripheral pulmonary lesions: a randomized trial

75 Effect of Lumacaftor/Ivacaftor on Pulmonary Exacerbation Rates in Members with Cystic Fibrosis in a Medicaid Population.

76 Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations

77 Prevalência de hipertensão pulmonar avaliada por ecocardiografia Doppler em uma população de pacientes adolescentes e adultos com fibrose cística Prevalence of pulmonary hypertension evaluated by Doppler echocardiography in a population of adolescent and adult patients with cystic fibrosis

78 The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high dose bolus administration of vitamin D3 during acute pulmonary exacerbation of cystic fibrosis

79 Mass screening for active case finding of pulmonary tuberculosis in the Russian Federation: how to save costs.

80 Galgeun-tang Attenuates Cigarette Smoke and Lipopolysaccharide Induced Pulmonary Inflammation via IκBα/NF-κB Signaling.

81 Perspectives on Burnout from Pulmonary, Critical Care, and Sleep Medicine Division Directors.

82 Physical Activity and Sedentary Behaviour Patterns in 326 Persons with COPD before Starting a Pulmonary Rehabilitation: A Cluster Analysis.

83 Purinergic Signaling in Pulmonary Inflammation.

84 Pulmonary Endarterectomy Surgery for Chronic Thromboembolic Pulmonary Hypertension: A Small-Volume National Referral Center Experience.

85 Noninfectious causes of diffuse pulmonary infiltrations in chronic renal failure: metastatic pulmonary calsification.

86 Role of Electrocardiographic Manifestations in Admission Decision in Patients with Chronic Obstructive Pulmonary Disease Exacerbation.

87 Progression of erectile function in men with chronic obstructive pulmonary disease: a cohort study.

88 A systematic review of the diagnostic accuracy of artificial intelligence-based computer programs to analyze chest x-rays for pulmonary tuberculosis.

89 Long-term effect of home-based pulmonary rehabilitation in severe asthma.

90 Spatial and temporal heterogeneity of panel-based tumor mutational burden (TMB) in pulmonary adenocarcinoma: separating biology from technical artifacts.

91 Clinical values of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

92 The methods for screening pulmonary hypertension related to systemic sclerosis in France: Descriptive survey of the French Research Group on Sclerosis

93 Long-term follow-up of persistent pulmonary pure ground-glass nodules with deep learning-assisted nodule segmentation.

94 Dried Yeast Extracts Curtails Pulmonary Oxidative Stress, Inflammation and Tissue Destruction in a Model of Experimental Emphysema.

95 Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China.

96 T-regulatory cells subpopulation in bronchial asthma and heterogeneous phenotypes of chronic obstructive pulmonary disease

97 miR-20a-5p regulates pulmonary surfactant gene expression in alveolar type II cells.

98 Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.

99 Nanocarrier Lipid Composition Modulates the Impact of Pulmonary Surfactant Protein B (SP-B) on Cellular Delivery of siRNA.

100 Ultrasound guided intra-amniotic instillation of pulmonary surfactant combined with ambroxol for prevention of lung injury in preterm rabbits

101 Interaction of inhalable volatile organic compounds and pulmonary surfactant: Potential hazards of VOCs exposure to lung

Keyword Connections

Journals

Research Groups

Bibliographies